← Leaderboards
Laurene Wang
Aimmax Therapeutics, Inc.
$3,663,308
Attributed
$3,663,308
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,663,308 · 2
By mechanism
R44$3,663,308 · 2
Top collaborators
No co-investigators on record.
Most similar at Aimmax Therapeutics, Inc.
Same institution · by research overlap
- Kara S Keedy$1,226,801
Others in their field
Other Rising Stars on “Fiber”
- Stavros Zanos · Feinstein Institute For Medical Research$7,425,595
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$5,909,618
- Sara Chester · The Industrial Commons$4,568,097
- Molly J Hemstreet · The Industrial Commons$4,568,097
- Melissa C Sharp · The Industrial Commons$4,568,097
- Anne L Wiper · The Industrial Commons$4,568,097
Research focus
FiberInjectableDoseExposure ToFrequenciesInfectionClinical TrialsCephalosporinsDrug InteractionsEvaluationFormulationBactericideAntibioticsGonorrheaAntibiotic TherapyAbsorptionAntimicrobialCanis FamiliarisCardiovascular SystemCeftriaxoneDrug KineticsDrug-Resistant GonorrheaAntibiotic ResistanceIntramuscular Injections
Grant awards (5)
Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea$1,049,943
R44 · FY2025 · AI · contact PI
Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea$999,991
R44 · FY2024 · AI · contact PI
A Single Dose Therapy to Treat Drug Resistant Gonorrhea$306,497
R44 · FY2024 · AI · contact PI
Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea$999,962
R44 · FY2023 · AI · contact PI
Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea$306,915
R44 · FY2022 · AI · contact PI